Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Capital Expenditures (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of Capital Expenditures data on record, last reported at -$8.9 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 83.76% year-over-year to -$8.9 million; the TTM value through Dec 2025 reached $3.7 million, down 85.17%, while the annual FY2025 figure was $3.7 million, 85.17% down from the prior year.
  • Capital Expenditures reached -$8.9 million in Q4 2025 per TCNNF's latest filing, down from $11.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $189.0 million in Q3 2021 and bottomed at -$54.8 million in Q4 2024.
  • Average Capital Expenditures over 5 years is $24.0 million, with a median of $14.0 million recorded in 2025.
  • Peak YoY movement for Capital Expenditures: crashed 14611.25% in 2021, then soared 989.39% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $85.0 million in 2021, then tumbled by 59.61% to $34.3 million in 2022, then plummeted by 159.38% to -$20.4 million in 2023, then tumbled by 169.04% to -$54.8 million in 2024, then surged by 83.76% to -$8.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were -$8.9 million in Q4 2025, $11.2 million in Q3 2025, and -$15.4 million in Q2 2025.